The first "Chinese" disitamab vedotin successfully goes abroad and has been approved for listing by the U.S. FDA
On September 2nd, HENLIUS announced that two products of its developed and produced Duzallo injection have been approved by the U.S. FDA for marketing, used for the treatment of osteoporosis and eight other indications related to bone events, making it the first domestically produced Duzallo approved overseas. Currently, HENLIUS has three products approved in the United States
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments